Abstract:Importance: Accumulating evidence indicates that higher blood pressure (BP) variability from one physician office visit to the next (hereafter referred to as visit-to-visit BP variability) is associated with poor outcomes. Short-term measurement (throughout 1 year) of visit-to-visit BP variability in high-risk older patients may help identify patients at increased risk of death.Objective: To evaluate whether short-term visit-to-visit BP variability is associated with increased long-term mortality risk.Design, Setting, and Participants: The US cohort of the International Verapamil SR-Trandolapril Study (INVEST), a randomized clinical trial of 16 688 patients aged 50 years or older with hypertension and coronary artery disease, was conducted between September 2, 1997, and December 15, 2000, with in-trial follow-up through February 14, 2003. The study evaluated a calcium antagonist (sustained-release verapamil plus trandolapril) vs β-blocker (atenolol plus hydrochlorothiazide) treatment strategy. Blood pressure measurement visits were scheduled every 6 weeks for the first 6 months and biannually thereafter. Statistical analysis was performed from September 2, 1997, to May 1, 2014.Exposures: Visit-to-visit systolic BP (SBP) and diastolic BP variability during the first year of enrollment using 4 different BP variability measures: standard deviation, coefficient of variation, average real variability, and variability independent of the mean.Main Outcomes and Measures: All-cause death, assessed via the US National Death Index, beginning after the exposure assessment period through May 1, 2014.Results: For the present post hoc analysis, long-term mortality data were available on 16 688 patients (9001 women [54%]; mean [SD] age, 66.5 [9.9] years; 45% White patients, 16% Black patients, and 37% Hispanic patients). During a mean (SD) follow-up of 10.9 (4.2) years, 5058 patients (30%) died. All 4 variability measures for SBP were significantly associated with long-term mortality after adjustment for baseline demographic characteristics and comorbidities. After comparison of lowest vs highest variability measure quintiles, the magnitude of the association with death remained statistically significant even after adjustment for baseline demographic characteristics and comorbidities (average real variability: adjusted hazard ratio [aHR], 1.18; 95% CI, 1.08-1.30; standard deviation: aHR, 1.14; 95% CI, 1.04-1.24; coefficient of variation: aHR, 1.15; 95% CI, 1.06-1.26; variability independent of the mean: aHR, 1.15; 95% CI, 1.05-1.25). The signal was stronger in women compared with men. Associations of diastolic BP variability measures with death were weaker than for SBP and were not significant after adjustment.Conclusions and Relevance: This study suggests that, in a large population of older patients with hypertension and coronary artery disease, short-term visit-to-visit SBP variability was associated with excess long-term mortality, especially for women. Efforts to identify and minimize visit-to-visit SBP variability may be important in reducing excess mortality later in life.Trial Registration: ClinicalTrials.gov Identifier: NCT00133692.

PREDICTIVE VALUE COMPARISON OF BLOOD PRESSURE VARIABILITY, CUMULATIVE BLOOD PRESSURE, AND BLOOD PRESSURE TRAJECTORY FOR CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY

Comparison of BP Variability, Cumulative BP, and BP Trajectory for Predicting Cardiovascular Events in the General Population.

Study of the relationship between blood pressure variability and arrhythmia of patients with essential hypertension

Longitudinal Change in Blood Pressure is Associated with Cardiovascular Disease Mortality in a Chinese Cohort.

Associations between long-term blood pressure trajectory and all-cause and CVD mortality among old people in China

Long‐term Predialysis Blood Pressure Variability and Outcomes in Hemodialysis Patients

Predictive value of within-visit and visit-to-visit blood pressure variability for all-cause mortality: the Minhang Study

Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study

Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study

Blood Pressure Trajectories During Young Adulthood and Cardiovascular Events in Later Life

Baseline and Longitudinal Change in Blood Pressure and Mortality in a Chinese Cohort

Blood Pressure Variability and the Progression of Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Blood pressure variability supersedes heart rate variability as a real-world measure of dementia risk

Intra-dialytic Blood Pressure Variability is a Greater Predictor of Cardiovascular Events in Hemodialysis Patients

Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease

Is "usual" Blood Pressure A Proxy for 24-H Ambulatory Blood Pressure in Predicting Cardiovascular Outcomes?

Baseline and Cumulative Blood Pressure in Predicting the Occurrence of Cardiovascular Events

Visit-To-Visit Office Blood Pressure Variability Combined With Framingham Risk Score To Predict All-Cause Mortality: A Post Hoc Analysis Of The Systolic Blood Pressure Intervention Trial

Prognostic Value of Short-Term Blood Pressure Variability over 24 H in 8938 Subjects from 11 Populations

Four-Limb Blood Pressure As Predictors of Mortality in Elderly Chinese

Associations of traditional cardiovascular risk factors with 15-year blood pressure change and trajectories in Chinese adults: a prospective cohort study